{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:50:09Z","timestamp":1791078609033,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.nbd.2008.03.010","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T18:01:26Z","timestamp":1208455286000},"page":"80-88","source":"Crossref","is-referenced-by-count":107,"title":["Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Hua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona K.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Slow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Bezprozvanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2008.03.010_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1212\/WNL.42.4.733","article-title":"Alternative excitotoxic hypotheses","volume":"42","author":"Albin","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2008.03.010_bib2","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.2628045100","article-title":"A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila","volume":"100","author":"Apostol","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.03.010_bib3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.03.010_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?","volume":"31","author":"Beal","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.03.010_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.03.010_bib6","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease","volume":"11","author":"Beal","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","article-title":"Deranged neuronal calcium signaling and Huntington disease","volume":"322","author":"Bezprozvanny","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2008.03.010_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2008.03.010_bib9","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.03.010_bib10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.03.010_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/hmg\/7.5.783","article-title":"Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture","volume":"7","author":"Cooper","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.03.010_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.03.010_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-M","article-title":"Excitotoxic injury of the neostriatum: a model for Huntington's disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib14","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.4356-06.2007","article-title":"Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease","volume":"27","author":"Fan","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib15","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","article-title":"Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease","volume":"27","author":"Fernandes","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib16","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.nbd.2005.08.007","article-title":"Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models","volume":"21","author":"Graham","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2008.03.010_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.03.010_bib19","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.03.010_bib20","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-4886(90)90014-J","article-title":"A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon","volume":"108","author":"Hantraye","year":"1990","journal-title":"Exp. Neurol."},{"issue":"Suppl 4","key":"10.1016\/j.nbd.2008.03.010_bib22","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.1073\/pnas.182426599","article-title":"Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay","volume":"99","author":"Heiser","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.03.010_bib23","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1046\/j.1471-4159.2000.0752163.x","article-title":"Mice transgenic for the Huntington's disease mutation are resistant to chronic 3-nitropropionic acid-induced striatal toxicity","volume":"75","author":"Hickey","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.03.010_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.nbd.2005.07.007","article-title":"Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease","volume":"21","author":"Hockly","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2008.03.010_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/brain\/awh058","article-title":"Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model","volume":"127","author":"Jarabek","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.03.010_bib26","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2008.03.010_bib27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntington aggregates may not predict neuronal death in Huntington's disease","volume":"46","author":"Kuemmerle","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.03.010_bib28","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib29","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1152\/jn.00308.2004","article-title":"Enhanced striatal NR2B-containing N-methyl-d-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease","volume":"92","author":"Li","year":"2004","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2008.03.010_bib30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jnr.10100","article-title":"Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice","volume":"67","author":"MacGibbon","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2008.03.010_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-328X(00)00276-X","article-title":"Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons","volume":"86","author":"Mao","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2008.03.010_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","article-title":"Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids","volume":"263","author":"McGeer","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.03.010_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington's disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2008.03.010_bib34","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1113\/jphysiol.2007.142448","article-title":"Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load","volume":"585","author":"Milnerwood","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2008.03.010_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0361-9230(00)00238-0","article-title":"Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity","volume":"52","author":"Morton","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2008.03.010_bib36","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","article-title":"Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors","volume":"26","author":"Oliveira","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1471-4159.2006.04361.x","article-title":"Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice","volume":"101","author":"Oliveira","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.03.010_bib38","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/exnr.2002.7885","article-title":"Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease","volume":"175","author":"Petersen","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2008.03.010_bib40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","article-title":"Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders","volume":"35","author":"Ross","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.03.010_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","article-title":"Lessons from animal models of Huntington's disease","volume":"18","author":"Rubinsztein","year":"2002","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2008.03.010_bib42","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2008.03.010_bib43","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.08.001","article-title":"Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease","volume":"21","author":"Shehadeh","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2008.03.010_bib44","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.03.010_bib45","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions","volume":"102","author":"Slow","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.03.010_bib46","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1006\/nbdi.2001.0438","article-title":"Inhibition of polyglutamine aggregation in R6\/2 HD brain slices-complex dose\u2013response profiles","volume":"8","author":"Smith","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2008.03.010_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.20651","article-title":"Alterations in N-methyl-d-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6\/2 mouse model of Huntington's disease","volume":"82","author":"Starling","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2008.03.010_bib48","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-d-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2008.03.010_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease","volume":"10","author":"Tanaka","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2008.03.010_bib50","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington's disease","volume":"27","author":"Tang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.03.010_bib52","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.03.010_bib53","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.03.010_bib54","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0962-8924(00)01853-5","article-title":"Huntington's disease: the challenge for cell biologists","volume":"10","author":"Tobin","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.nbd.2008.03.010_bib55","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","article-title":"Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases","volume":"145","author":"Trushina","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2008.03.010_bib56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2008.03.010_bib57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2006.08.036","article-title":"Evaluation of clinically-relevant glutamate pathway inhibitors in in vitro model of Huntington's disease","volume":"407","author":"Wu","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2008.03.010_bib58","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.03.010_bib59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2008.03.010_bib60","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.0408936102","article-title":"A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T09:15:12Z","timestamp":1557479712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996108000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0969996108000661"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2008.03.010","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}